Theravance Biopharma (TBPH) Gross Profit (2013 - 2018)
Theravance Biopharma (TBPH) posted quarterly Gross Profit of $15.1 million for Q4 2018, up 581.94% year-over-year from $2.2 million in Q4 2017, and up 24.5% quarter-over-quarter from $12.1 million in Q3 2018.
Theravance Biopharma (TBPH) Gross Profit (2013 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has reported Gross Profit for 6 consecutive years, with $15.1 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Gross Profit rose 581.94% year-over-year to $15.1 million; the TTM figure through Dec 2018 stood at $56.8 million (up 457.99% YoY), while the FY2018 annual figure was $59.7 million, up 537.61% from the prior year.
- Gross Profit advanced to $15.1 million in Q4 2018 per TBPH's latest filing, from $12.1 million in the prior quarter.
- Across five years, Gross Profit topped out at $22.0 million in Q2 2018 and bottomed at -$1.8 million in Q4 2014.
- Historically, Gross Profit has averaged $8.4 million across 5 years, with a median of $6.3 million in 2014.
- On a YoY basis, Gross Profit climbed as much as 53800.0% in 2014 and fell as far as 1122.29% in 2014.
- Theravance Biopharma's Gross Profit stood at -$1.8 million in 2014, then surged by 138.68% to $692000.0 in 2015, then soared by 556.94% to $4.5 million in 2016, then tumbled by 51.28% to $2.2 million in 2017, then jumped by 581.94% to $15.1 million in 2018.
- Business Quant data shows TBPH's Gross Profit at $15.1 million in Q4 2018, $12.1 million in Q3 2018, and $22.0 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 15.11 Mn |
| Dec 31, 2018 | 15.11 Mn |
| Sep 30, 2018 | 12.13 Mn |
| Sep 30, 2018 | 12.13 Mn |
| Jun 30, 2018 | 22.03 Mn |
| Jun 30, 2018 | 22.03 Mn |
| Mar 31, 2018 | 7.49 Mn |
| Mar 31, 2018 | 7.49 Mn |
| Dec 31, 2017 | 2.22 Mn |
| Dec 31, 2017 | 2.22 Mn |
| Sep 30, 2017 | 3.29 Mn |
| Sep 30, 2017 | 3.29 Mn |
| Jun 30, 2017 | 2.15 Mn |
| Jun 30, 2017 | 2.15 Mn |
| Mar 31, 2017 | 2.52 Mn |
| Mar 31, 2017 | 2.52 Mn |
| Dec 31, 2016 | 4.55 Mn |
| Dec 31, 2016 | 4.55 Mn |
| Sep 30, 2016 | 18.74 Mn |
| Sep 30, 2016 | 18.74 Mn |